OTLK Logo

Outlook Therapeutics, Inc. (OTLK) 

NASDAQ
Market Cap
$167.35M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
67 of 809
Rank in Industry
53 of 445

Largest Insider Buys in Sector

OTLK Stock Price History Chart

OTLK Stock Performance

About Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Insider Activity of Outlook Therapeutics, Inc.

Over the last 12 months, insiders at Outlook Therapeutics, Inc. have bought $5.05M and sold $0 worth of Outlook Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Outlook Therapeutics, Inc. have bought $9.86M and sold $484,554 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Syntone Ventures LLC (10 percent owner) — $5M. Evanson Jeff (CHIEF COMMERCIAL OFFICER) — $26,243. Haddadin Yezan Munther (director) — $22,242.

The last purchase of 714,286 shares for transaction amount of $5M was made by Syntone Ventures LLC (10 percent owner) on 2024‑04‑15.

List of Insider Buy and Sell Transactions, Outlook Therapeutics, Inc.

2024-04-15PurchaseSyntone Ventures LLC10 percent owner
714,286
2.6874%
$7.00$5M-11.02%
2024-03-28PurchaseHaddadin Yezan Muntherdirector
1,881.71
0.0143%
$11.82$22,242-33.39%
2024-03-07PurchaseEvanson JeffCHIEF COMMERCIAL OFFICER
62,484
0.0245%
$0.42$26,243-4.01%
2023-04-20SaleDagnon TerryChief Operations Officer
520,000
0.2181%
$1.14$590,200-62.27%
2023-01-20SaleEvanson JeffChief Commercial Officer
267,000
0.1196%
$1.11$296,370-0.92%
2023-01-19SaleEvanson JeffChief Commercial Officer
103,255
0.0462%
$1.22$125,971-10.00%
2023-01-18SaleEvanson JeffChief Commercial Officer
33,738
0.015%
$1.25$42,173-12.90%
2023-01-17SaleEvanson JeffChief Commercial Officer
27,162
0.0122%
$1.31$35,582-15.63%
2022-10-07PurchaseSukhtian Faisal Ghiathdirector
30,000
0.0135%
$1.29$38,700-9.92%
2022-10-07PurchaseHaddadin Yezan Muntherdirector
3,600
0.0016%
$1.27$4,572-9.92%
2022-10-06PurchaseHaddadin Yezan Muntherdirector
29,743
0.0134%
$1.29$38,368-9.52%
2022-10-05PurchaseHILZINGER KURT Jdirector
15,662
0.0068%
$1.23$19,264-8.80%
2022-10-04PurchaseHILZINGER KURT Jdirector
95,541
0.0427%
$1.29$123,248-10.24%
2022-09-29PurchaseHILZINGER KURT J
88,797
0.0438%
$1.24$110,500-3.36%
2022-06-21PurchaseDagnon TerryChief Operating Officer
10,000
0.0045%
$1.05$10,500+8.57%
2022-06-21PurchaseTRENARY C RUSSELL IIICEO and President
19,925
0.0091%
$1.06$21,121+8.57%
2022-03-01PurchaseHILZINGER KURT Jdirector
27,708
0.0127%
$1.69$46,827-30.95%
2022-02-28PurchaseHILZINGER KURT Jdirector
6,000
0.0027%
$1.60$9,600-28.83%
2022-02-24PurchaseHILZINGER KURT Jdirector
41,160
0.0167%
$1.46$60,094-28.66%
2022-02-23PurchaseHILZINGER KURT Jdirector
79,535
0.0371%
$1.44$114,530-17.02%

Insider Historical Profitability

50.18%
Syntone Ventures LLC10 percent owner
1705438
7.6167%
$7.1530+28.25%
Evanson JeffChief Commercial Officer
808459
0.2866%
$7.1526
Haddadin Yezan Muntherdirector
5049
0.0243%
$7.1560+52.96%
Sukhtian Ghiath M.
27834257
10.6949%
$7.1520+92.17%
Mohan Pankaj
7064553
2.7145%
$7.1514
Dagnon TerryChief Operations Officer
653058
0.2509%
$7.1533+8.57%
HILZINGER KURT Jdirector
473117
0.1818%
$7.15340<0.0001%
Griffith Donald J.director
144926
0.0557%
$7.1501
Gangloff Scott A.SVP, Development & Mfrg
78573
0.0302%
$7.1501
Sukhtian Faisal Ghiathdirector
68000
0.0261%
$7.1540+77.69%
Yamashita Elizabeth A.VP, Regulatory Affairs
64648
0.0248%
$7.1503
TRENARY C RUSSELL IIICEO and President
54925
0.0211%
$7.1530+8.57%
MCANDREW STEPHEN JSVP Bus. Strat. & Dev.
50899
0.0196%
$7.1502
Bahrt KennethChief Medical Officer
47120
0.0181%
$7.1512
KENYON LAWRENCE ACEO, Pres, CFO, Treas & Secy
18926
0.0073%
$7.1523+17.42%
THURMAN RANDY Hdirector
11875
0.0046%
$7.1520+247.3%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Tang Capital Management, LLC$19.34M6.921.62MNew+$19.34M0.08
Great Point Partners$17.67M6.321.48MNew+$17.67M2.96
Armistice Capital Llc$8.53M3.05714,285New+$8.53M0.1
Sphera Fund$6.82M2.44571,429New+$6.82M1.13
BlackRock$6.02M2.15503,988-95.14%-$117.76M<0.0001
Velan Capital$5.97M2.14500,000New+$5.97M3.25
Caligan Partners LP$5.97M2.14500,000New+$5.97M1.58
The Vanguard Group$4.08M1.46341,300-94.8%-$74.26M<0.0001
Schonfeld Group$3.2M1.22285,714New+$3.2M0.02
Geode Capital Management$1.81M0.65151,580-94.9%-$33.66M<0.0001
State Street$1.79M0.64150,116-94.69%-$31.96M<0.0001
Northern Trust$729,689.000.2661,113-95.55%-$15.67M<0.0001
Bank of America$692,305.000.2557,982-73.16%-$1.89M<0.0001
Walleye Capital$400,050.000.1433,505New+$400,050.00<0.01
Hrt Financial Llc$341,000.000.1228,623New+$341,000.00<0.01
Millennium Management LLC$331,263.000.1227,744-89.93%-$2.96M<0.0001
Scotia Capital Inc$282,918.000.123,695-91.66%-$3.11M<0.01
BNY Mellon$238,597.000.0919,983-95.4%-$4.95M<0.0001
Virtu Financial Llc$217,000.000.0818,213-73.27%-$594,930.050.02
Charles Schwab$211,696.000.0817,730-95%-$4.02M<0.0001
Renaissance Technologies$210,000.000.0817,600-83.31%-$1.05M<0.0001
Jane Street Capital$161,763.000.0613,548-74.38%-$469,659.55<0.0001
Morgan Stanley$142,958.000.0511,973-97.63%-$5.88M<0.0001
LINSCO PRIVATE LEDGER CORP$132,056.000.0511,060-94.5%-$2.27M<0.0001
Royal Bank of Canada$127,000.000.0510,624-79.68%-$498,042.26<0.0001
Gables Capital Management Inc$116,117.000.049,725-93.36%-$1.63M0.06
RhumbLine Advisers$115,166.000.049,646-95.02%-$2.2M<0.0001
UBS$111,316.000.049,323-92.59%-$1.39M<0.0001
Ancora Advisors Llc$72,834.000.036,100-95%-$1.38M<0.01
Barclays$66,000.000.025,496-97.45%-$2.53M<0.0001
American International Group$46,244.000.023,873-95.05%-$887,173.17<0.0001
JPMorgan Chase$44,190.000.023,701-96.33%-$1.16M<0.0001
Armstrong Advisory Group Inc$1.41M0.023,5800%+$00.14
Wells Fargo$27,999.000.012,345-94.21%-$455,888.20<0.0001
Northwestern Mutual Wealth Management Co$25,373.000.012,125New+$25,373.00<0.0001
New York State Common Retirement Fund$22,000.000.011,813-95%-$418,036.40<0.0001
Citigroup$18,567.000.011,555-93.59%-$271,293.12<0.0001
CalSTRS$10,567.00<0.01885-96.58%-$298,526.71<0.0001
Legal & General$9,899.00<0.01829-95%-$188,200.41<0.0001
Fidelity Investments$8,036.00<0.01673-97.4%-$301,021.63<0.0001
Ameritas Investment Partners Inc$7,248.00<0.01607-95%-$137,795.58<0.0001
Tower Research Capital$6,089.00<0.01510-97.78%-$267,999.58<0.0001
Deutsche Bank$6,125.00<0.01513-95.01%-$116,697.37<0.0001
CWM LLC$3,000.00<0.01283-95%-$57,000.00<0.0001
Amalgamated Bank$2,000.00<0.01153-99.23%-$256,758.17<0.0001
Advisor Group Holdings Inc$2,424.00<0.01203-99.5%-$481,635.66<0.0001
Soa Wealth Advisors Llc$3,582.00<0.01300New+$3,582.00<0.01
Steward Partners Investment Advisory LLC$167.00<0.0114New+$167.00<0.0001
Prestige Wealth Management Group$741.00<0.0162-95.04%-$14,198.52<0.0001
Larson Financial Group Llc$1,194.00<0.01100-95%-$22,686.00<0.0001